QPPV.COM KNOWLEDGE ASSESSMENT

Pharmacovigilance Reconciliation: Professional Knowledge Assessment

Test your understanding of the concepts covered by Pharmacovigilance Reconciliation: What Should Be Reconciled, With Whom and How Often?.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A process has had no recorded discrepancies for several months, but its reconciliation checks only items preselected by staff. What is the most defensible conclusion?
Question 2 of 10 Which record is most useful for making a reconciliation extraction reproducible and auditable?
Question 3 of 10 A company is designing a reconciliation for a registry that collects a broad range of adverse events, while the PV system records individual cases meeting applicable reporting criteria. Which approach is best?
Question 4 of 10 A team proposes closing every discrepancy once it has been removed from the worklist. What is the key weakness in this approach?
Question 5 of 10 A monthly reconciliation identifies an unmatched source item that may describe a serious suspected adverse reaction. What should the reviewer do first?
Question 6 of 10 A team proposes reconciling only monthly totals because the sending and receiving systems do not share record identifiers. Which interpretation is most appropriate?
Question 7 of 10 A process has a high match rate, but its report does not state exclusions or explain whether one source record can map to multiple PV records. What is the main interpretive limitation?
Question 8 of 10 A literature reference has been reviewed and documented as a duplicate of an existing case. How should this ordinarily be handled in a reconciliation?
Question 9 of 10 A reviewer finds a mismatch caused by one system using local time and the other using a different time zone near a period boundary. What is the best corrective approach?
Question 10 of 10 Which statement best reflects the article's regulatory interpretation of reconciliation frequency?

Select an answer to continue.

QPPV.com